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The Friend  virus complex  (Friend  LV) 1 (1,  2)  induces  erythroleukemias  in  mice. 
The  replication-defective  component  of  Friend  LV,  spleen  focus-forming  virus 
(SFFV), includes in its genome a  gene whose expression transforms infected erythro- 
blastic  cells.  SFFV  depends  on  coinfection  with  a  competent  helper  virus,  Friend 
murine leukemia virus (FMuLV), for a portion of its replicative cycle. Each coinfecting 
virus expresses gene products, some of which become located on the host cell surface 
and function as tumor-specific antigens. 
Cultured  lines  of cells  transformed  in  vivo by leukemogenic  viruses  have  served 
widely in studies of the immune response to these cell surface antigens. Our laboratory 
has  studied  the  H-2-restricted  cytolytic  T  lymphocyte  (CTL)  component  of this 
response using a series of Friend LV-induced erythroleukemia cell lines derived from 
mice  of strains  congenic  with  BALB/c  but  differing  with  respect  to  their  H-2 
haplotypes  (3).  Although  this  CTL  response  has  viral  specificity,  the  viral  proteins 
bearing  the specificities  have not  been  identified  with  certainty.  However,  it  seems 
clear that both the SFFV and FMuLV genomes code for molecules with the capacity 
to generate a  CTL response under appropriate conditions (4, 5). 
These studies represent  a  preliminary analysis of clones of the previously uncloned 
line of erythroleukemia cells, HFL/b, induced in a  BALB.B mouse by Friend LV (6). 
Studies of viral antigen expression by virus-producer and -nonproducer clones of this 
line revealed no major serologically detectable  differences, but virus-producer clones 
were  markedly  more  sensitive  to  lysis  by  syngeneic  Friend  LV-specific  CTL  than 
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nonproducer clones. However, virus-producer clones appeared to be less efficient than 
nonproducer clones as stimulators of CTL generation in syngeneic mixed leukocyte- 
tumor  cell  cultures  (MLTC).  Our  results  thus  indicate  that  virus  production  or 
nonproduction by  HFL/b  tumor  cells  is  an  important  variable  with  a  complex 
influence on the Friend LV-specific CTL response. 
Materials and Methods 
Mice.  Mice of the inbred congenic strains BALB.B  (H-2  b) and BALB/c (H-2 d) were bred 
in our colony at the Albert Einstein College of Medicine, Bronx, N. Y. 
Tumor Cells.  HFL/b cells were derived from the spleen of a BALB.B  mouse with erythro- 
leukemia induced by Friend LV (6). RBL-5 cells came from a lymphoma induced in a C57BL/ 
6 mouse (H-2  b) by Rauscher leukemia virus (LV)  (7). LSTRA cells were inducecl in a BALB/ 
c  mouse by Moloney LV  (8). B.GV cells  were derived from  a  BALB.B  Gross  LV-induced 
leukemia (9). These four tumors were maintained as continuous suspension cell  cultures in 
Eagle's minimal essential medium (MEM) supplemented with 20% fetal bovine serum (FBS). 
Each culture was passaged about every 4 d  by transferring 106 cells into 5 ml fresh  culture 
medium. 
Cloning Procedure.  HFL/b cells were cloned by limiting  dilution. Cell suspensions containing 
one cell in 40/xl were distributed in 10-#l aliquots into 60-well tissue culture microplates (Falcon 
Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) and examined to identify wells 
containing a  single cell.  These wells  were  refed  4  d  later,  and the clones were  allowed to 
proliferate.  When sufficiently expanded, the  clones were  passaged  every 4  d  as suspension 
cultures. Plating efficiency for HFL/b cells was ~62%. 
Virus Assays.  Each culture to be assayed for virus production was initiated with 5 ×  106 cells 
in 5 ml fresh tissue culture medium and incubated for 24 h at 37°C. Culture supernates were 
collected and centrifuged once at 600 g for 5 min and again at  1,500 g for  10 min, and then 
tested for the presence of virus particles with one or more of the following methods: 
(a) Assay for Reverse Transcriptase (RTase) Activity.  Each cell-free  supernate was cleared by 
centrifugation at 5,900 g for 7 rain. The virus particles were then pelleted by centrifugation at 
108,000 g for 90 min and resuspended in 50/~1 phosphate-buffered saline, pH 7.2 (PBS). The 
RTase activity of these viral preparations was measured with a modification (10) of the method 
of Scolnick and Parks (11). 
(b) Spleen Focus Assay.  The presence of Friend LV in the cell-free  culture supernates was 
detected  in vivo with the assay of Axelrad and Steeves  (12),  which measures SFFV in the 
presence of FMuLV. Supernate dilutions ranging from 1/1  to  1/1,000 (in PBS) were injected 
intravenously into the lateral tail vein of BALB/c mice in 1-ml vol. The mice were killed 9 d 
later, and the spleens were removed and fixed in Bouin's solution. Discrete macroscopic focal 
lesions on the surface of the spleen were counted, and virus titers were expressed  in spleen focus- 
forming units (SFFU) per ml culture supernate. 
(c) XC Cell Line Plaque Assay.  A modification of the method of Rowe et al. (13) was used to 
measure the activity of helper FMuLV in cell-free  culture supernates, as described recently 
(14). Serial dilutions of culture supernates were used to infect a clonal derivative of SC-1 mouse 
cells (obtained from Dr. P. O'Donnell, Memorial Sloan-Kettering  Cancer Institute, New York), 
and the presence of FMuLV was revealed by syncytial plaque formation in the cultures after 
overlaying with rat XC cells. Virus titers were calculated in terms of plaque-forming units 
(PFU) per ml culture supernate. 
(d)  Equilibrium Density Gradient Centrifugation of Labeled Virus Particles.  HFL/b  cells  were 
suspended in 15 ml complete culture medium at  106 cells per ml, and 200 p.Ci [5,6-aH]uridine 
or [2-14C]uridine (Amersham Corp., Arlington Heights, Ohio) was added. After a 6-h pulse at 
37°C, the cells were centrifuged at 600 g and the cell  pellet was  resuspended in  10 ml fresh 
culture medium. The cells were further incubated for 16 h at 37°C, and the culture supernates 
were cleared as  described above.  10  ml supernate was  layered on a  linear 20-60% sucrose 
gradient (7  ml)  and centrifuged at  94,500  g  for 3 h.  The tube was punctured, and 3-drop 
fractions were collected from the bottom. The refractive index of each fraction was determined, 
and each fraction was counted differentially  for fl-radioaetivity  in a well-type liquid scintillation 
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Radioimmunoassay.  Cell-surface antigens were detected with a radioimmunoassay using ~25I- 
labeled Staphylococcus aureus protein A,  which  binds to  the  Fc  portion of immunoglobulin, 
according to the method of Dorval et al. (15). Purified protein A (Pharmacia Fine Chemicals, 
Inc., Uppsala, Sweden) was iodinated with Na[~25I] by the chloramine-T-coupllng  procedure of 
Hunter and  Greenwood  (16). Radiolabeled protein A  was  separated  from  free  iodine by 
Sephadex  G-25  (Pharmacia  Fine Chemicals,  Div.  of Pharmacia,  Inc.,  Piscataway,  N. J.) 
chromatography and stored at -70°C. The radioimmunoassay was initiated by incubating 10  ~ 
cells in 100 ffl MEM with 10 #1 antiserum (diluted serially in MEM) in 6- ×  50-mm glass test 
tubes for 60 rain at 4°C. After three washes  in 2 ml MEM, the cells were resuspended in 100 
pl MEM and incubated with 2 X 105 counts of a2~I-protein A for 30 min at 4°C. The cells were 
washed three times, and the final cell pellet was counted for radioactivity in a well-type gamma 
(Searle Radiographics Inc., Des Plaines, Ill.) counter. The relative degree of x2~I-labeled  protein 
A binding was calculated according to the formula: 
EB -  BB 
Percent binding --  ×  100, 
MB  -  BB 
where EB is the experimental binding; BB, the background binding  in the absence of antiserum; 
and MB, the maximum binding obtained with a positive serum under saturating conditions. 
The absence of Fc receptors on HFL/b cells was confirmed by incubation  of the cells in normal 
mouse serum or in irrelevant antisera; in both cases 125I binding  was equivalent to background 
binding in the absence of serum. 
Antisera.  Mouse anti-H-2.2 serum (anti-H-2D ~ serum) was  prepared in our laboratory by 
hyperimmunizing (A  ×  HTI)F1 mice with  EL4  (H-2 b)  leukemia cells.  Mouse anti-HFL/b 
serum was also prepared in our laboratory by repeated immunization of BALB.B  mice with 
HFL/b cells. Goat antisera to Rauscher LV gp69/71, p30, and p12 antigens were  obtained 
through the Office of Program  Resources and Logistics,  Viral Oncology Division, National 
Cancer Institute, Bethesda, Md. All antisera were heat-inactivated at 56°C for 30 min. 
Lymphocyte Cultures.  Friend LV-specific CTL were generated in culture from spleen cells of 
BALB.B mice primed intraperitoneally  20-30 d previously with 5 ×  10  ° HFL/b cells inactivated 
by a 20-see fixation in 0.15% glutaraidehyde (17). Syngeneic MLTC (18) were established in 
upright tissue culture flasks in 20 ml RPMI-1640 medium (Grand Island Biological Co., Grand 
Island, N. Y.) supplemented with 5% FBS and 5 X  10  -5 M  2-mercaptoethanol, by mixing 2.5 
×  107 spleen cells with  1 ×  106 x-irradiated (5,000 rad) syngeneic HFL/b cells. Cultures were 
harvested after incubation  for 6-7 d and were assayed for cytolytic activity with the ~aCr-release 
cytotoxicity assay. 
Secondary MLTC were also established as microcultures by incubating 5.0 ×  106 HFL/b- 
immune BALB.B spleen cells with various numbers of x-irradiated (5,000 rad) or glutaralde- 
hyde-fixed HFL/b cells in 2 ml MLTC medium. Glutaraldehyde fixation was  performed as 
described by Bubbers and Henney (17), except that after fixation, the cells were incubated at 
0°C for 24 h in serum-free MEM. 
Allogeneic secondary mixed leukocyte cultures (MLC)  were established to generate CTL 
specific  for H-2 n antigens. BALB/c  (H°2 a)  mice were  immunized with  two  intraperitoneal 
injections of 3 ×  107 BALB.B  (H-2 b)  spleen cells, and secondary MLC were  established by 
mixing 2.5  ×  10  7 H-2b-immune BALB/c spleen cells with 2.5 X  10  v x-irradiated (1,000 rad) 
BALB.B spleen cells in 20 ml culture medium. 
5tCr-release Cytotoxicity Assay.  Cell-mediated cytolytic activity was detected by incubating 104 
5XCr-labeled target cells with lymphocytes harvested from MLTC or MLC at various lympho- 
cyte:target cell ratios, in a final vol of 0.2 ml in round-bottom multi-well plates according to 
the assay originally described by Brunner et al. (19). After incubation at 37°C for 6 or 15 h, the 
supernates were harvested and measured for radioactivity in a Searle well-type gamma counter. 
The percent specific 5~Cr release was calculated for each lymphocyte:target cell ratio according 
to the formula: 
ER -  SR 
Percent release  =  ×  100, 
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where ER was the experimental  SlCr release;  SR, the spontaneous 5XCr release detected after 
incubation of the target cells  in culture medium alone; and MR, the maximum 51Cr release 
obtained  after  incubation  of the  target  ceils  in  1  N  HCI  for  the  duration  of the  assay. 
Spontaneous release  (SR, see above) values varied between 8 and  20% of total incorporated 
label.  Dose-response curves were established for.each lymphocyte population assayed by plotting 
specific  cytolytic activity versus the log10 of the number of viable effector cells. The cytotoxic 
index (CI50) of each lymphocyte population was defined as the lymphocyte-to-target cell ratio 
giving 50% lysis of 10  target cells. 
The number of cytotoxic cells generated in micro-MLTC was quantitated  in terms of lyric 
units  (LU).  1 LU was defined  in our  HFL/b system as the number of viable MLTC cells 
necessary to lyse 20% of 10' 51Cr-labeled  HFL/b clone B-2 target cells during an incubation 
period of 6 h. This value was calculated graphically from the dose-response curves of cytolytic 
activity obtained with each micro-MLTC (cf. Fig. 5).  Results were expressed in terms of LU 
per 10°MLTC cells and of total LU recovered per microcuhure. 
Cold Target Cell Inhibition Assay.  CTL specificity for target antigens was analyzed by adding 
unlabeled (cold) competitor target cells tO the 51Cr-release cytotoxicity assay. Variable numbers 
of cold target cells were mixed in multi-well plates with  104 51Cr-labeled  target cells in 0.1 ml 
culture  medium;  3  ×  105 effector lymphocytes were subsequently  added  in 0.1  ml  culture 
medium to each well, and the plates were incubated for 6 h at 37°(2. The percent inhibition of 
cytotoxicity was calculated according to the formula: 
Cont -  Exp 
Percent inhibition =  ×  100, 
Cont 
where "Cont" was the specific cytotoxic activity detected  in wells  containing no cold target 
cells and "Exp" was the experimental cytotoxicity values obtained from wells containing cold 
target cells, effector lymphocytes, and 51Or-labeled  target cells. 
Results 
Heterogeneity among Clones of HFL/b Cells.  The HFL/b  tumor cell  line originated 
from the spleen of a  Friend LV-infected BALB.B mouse and was adapted  to growth 
as a  continuous line in culture, without cloning (6). HFL/b  cells revived from frozen 
storage  at  the  65th  passage  were  cloned  after  7  further  passages,  when  they  were 
producing relatively large amounts of infectious Friend LV.  17 clones were obtained, 
all of which produced virus particles as indicated  by release of sedimentable  RTase 
activity. This enzyme has been shown to be incorporated into oncornavirus particles 
(20). Wide variations in RTase activity (471-19,532 cpm)  were observed among the 
17 clones  (data  not shown), and  3 clones  (i.e.,  clones B, C, and  L)  were selected  for 
recloning. Clone B showed the highest index of virus production and clones C  and L, 
the lowest. 
Two subclones were obtained from clone B,  15 from clone C, and  19 from clone L. 
When culture supernates were assayed in vivo for the induction of spleen foci by the 
SFFV component of Friend LV (Fig.  1), subclones B-1 and B-2, as well as the initial 
clone B, proved to be high virus producers (titers ~  550 SFFU/ml).  Clone C  yielded 
a  majority  of subclones  which  produced  moderate  to  large  amounts  of infectious 
SFFV; however, two of the subclones, C-4 and C-10, produced very small amounts of 
virus (titers ___ 60 SFFU/ml).  Recloning of clone L  yielded  19 subclones which were 
all  moderate  to high Friend  LV producers;  in fact,  12  of these subclones  had  titers 
>700 SFFU/ml  (Fig.  1). These studies thus indicated that uncloned HFL/b  cultures 
consisted  of cells which were widely heterogeneous with  respect  to their capacity to 
produce infectious Friend LV. 
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producer to low producer or nonproducer status, occurring repeatably at about the 
same cumulative passage level, had been observed in the uncloned HFL/b cell line 
(10) and was again noted in the course of these experiments. Between passages 98 and 
132 (i.e., an interval of ~ 162 d of continuous culture) virus titers of culture supernates 
fell from >800 to 30 SFFU/ml  (Fig. 2). Parallel studies of Friend LV production by 
high producer clone B-2 and low producer clone C-4 (Fig. 2) showed that clone B-2 
cells retained the ability to produce large amounts of infectious Friend LV throughout 
the same period in which uncloned HFL/b cells stopped producing infectious virus 
(i.e., passages 6-40 for clone B-2). Furthermore, done B-2 cells have now maintained 
the ability to produce large amounts of infectious Friend LV for >18 mo in continuous 
culture. In contrast, clone C-4 cells produced very little infectious Friend LV; in fact, 
by passage 56, they had lost all capacity to produce detectable levels of virus (Fig. 2). 
These  data  thus  indicated  that  a  repressive  genetic  mechanism  occurring  in  a 
synchronous manner in each cell was apparently not the major cause of the transition 
to  nonproducer  status  observed  among  uncloned  HFL/b  cells.  Further  cloning 
experiments  (data  not  shown)  indicated  that  asynchrony  in  the  arrest  of virus 
production was not an alternative explanation for our observations. HFL/b cells were 
cloned at passage 165, when they were producing very low amounts of virus. 13 clones 
were derived, all of which were low virus producers, with titers ranging from 0 to 30 
SFFU/ml.  Similarly, high producer clone B-2 was subeloned at passage 66, and the 
28 clones obtained were all high producers of Friend LV (1,000-50,000 SFFU/ml). 
These findings appear to eliminate the possibility that  the  transition  from virus 
production to nonproduction by uncloned HFL/b cells was a genetically programmed 
event occurring quasi-synchronously in each cell. Rather, it seems likely that sponta- 
neous shutdown of virus production occurs as a  rare event in HFL/b cells, and that 
nonproducer cells then overgrow producer cells by virtue of a  slight  advantage  in 
growth rate. However, no difference was detected in the growth of producer B-2 cells 
compared with nonproducer C-4 cells. 
Surface Antigens of HFL/b Cloned Cells. HFL/b cells were assayed with specific antisera 
for a  variety of cell surface antigens with the protein A radioimmunoassay. Table I FERNANDO PLATA, MAUREEN  M.  G(X)DENOW,  AND FRANK LILLY 
800 
m~e 
1.1,1 
,~  700 
Z 
~oo 
.~  500 
U  400 
~E 
==  300 
..=  2oa  u.. 
Z 
,,=,  loo 
HFL/b 
clone  B2 
0  50  100  150  200  0  25  50  75 
PASSAGE  NUMBER 
FIG. 2.  Time-course of SFFV production by HFL/b cells. Uncloned HFL/b cells (11), as well as 
HFL/b subclones B-2 (0) and C-4 (C)) were assayed in vivo for SFFV production at various times 
during their continuous culture. The arrow in (A) indicates passage No. 72, when HFL/b cells were 
first cloned. Passage No. 1 of subclones B-2 and C-4 coincided with passage No. 92 of the uncloned 
HFL/b cells. 
TABLE  I 
Characterization of ttFL/b Clones B-2 and C-4 
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HFL/b  Passage 
clone  number 
Infectious virus  produc- 
tion  Cell surface antigens (BIs0)* 
SFFV  FMuLV  gp69/71  p30  p 12  HFL/b~  H-2.2 
SFFU/ml  PFU/ml 
B-2  61  2.2 ×  104  1.8 ×  103  70  <10  <10  18  10 
C-4  66  0  0  65  <10  <10  45  10 
* Determined with specific antisera by the protein A binding  assay. Data are expressed as the reciprocal of 
the antiserum dilution yielding 50% binding index values (BIs0), calculated from the graphed data. 
~: Cell surface antigens recognized  by BALB.B anti-HFL/b serum. 
summarizes a  typical experiment that  showed  that  no major antigenic differences 
could be detected between virus-producing  and -nonproducing  cloned cells. Although 
clone B-2 cells were producing large amounts of both SFFV and helper FMuLV and 
clone C-4 cells were  not, both clones bound comparable amounts of antibodies to 
viral envelope glycoprotein gp69/71.  Both clones were also recognized by BALB.B 
anti-HFL/b serum. This serum contains antibodies to glycoprotein gp69/71  and to 
FMR antigen, a cell-surface antigen commonly present on cells infected with Friend, 
Moloney, or Rauscher LV. Viral gag proteins p30 and p 12 were barely detectable on 
the surface of either type of cell. In addition, H-2.2 antigen (H-2D b) was present in 
both clones in equivalent amounts. 
The equivalence in viral antigen expression observed with cells from high producer 
clone B-2 and nonproducer clone C-4 could have resulted from  the production by 
clone B-4 cells of a  virus undetectable with  our assays.  Fig.  3  shows  that  this was 
probably not  the case:  attempts  to  label a  virus produced  by clone C-4 cells with 
[14C]uridine failed to reveal a  virus band after equilibrium density-gradient centrifu- 732  CYTOLYTIC T  LYMPHOCYTES  AND FRIEND VIRUS 
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FIG. 3.  Banding of labeled virus particles  by equilibrium density-gradient centrifugation. After 
pulse-chase  labeling of clone B-2  cells  (0)  with  [SH]uridine  and of clone C-4  cells  (O)  with 
[14C]uridine, 5 ml cell-free supernate from each culture was run on the same 20-60% sucrose linear 
gradient. After  centrifugation, fractions  were  collected  from  the bottom  of the tube and their 
refractive  indices determined. The radioactivity of each  fraction was counted differentially for SH 
and 14C, and was plotted as a function of the refractive index. 
lOO 
8o 
6o 
~ 4o 
20 
0 10  30  100  300  1~00 
ANTISERUM DILUTION (RECIPROCAL) 
Flo.  4.  Expression of gp69/71  on the surface of cloned HFL/b cells. Clone C and four subelones 
obtained from clone C were assayed with goat anti-Rauscher gp69/71  serum, using the protein A 
radioimmunoassay. &, clone C (high producer of Friend LV);  A, subclone C-14 (high producer of 
Friend LV);  S, subclone C-4  (low producer of Friend LV); Q, subclone C-10  (high producer of 
Friend LV); II, subclone C-15 (medium producer of Friend LV); I-I, normal BALB.B spleen cells. 
gation in a  20-60%  sucrose  linear gradient.  Similar labeling of clone B-2 cells with 
[SH]uridine  (as  opposed  to  [14C]uridine)  gave  rise  to  labeled  particles  that  banded 
between  1.146 and  1.161  g/em a in the same sucrose gradient (Fig. 3). 
That no major antigenic differences, as detected serologically, could be established 
between Friend LV-producing clones and -nonproducing clone C-4 was confirmed by 
the  data  shown  in Fig.  4,  in which  levels of virus production  by subclones derived 
from  clone  C  showed  no  correlation  with  expression  of viral  gp69/71  on  the  cell 
surface.  We  concluded  that,  notwithstanding  the  inability  to  produce  infectious FERNANDO  PLATA, MAUREEN M.  GOODENOW,  AND  FRANK LILLY 
TABLE II 
ttFL/b Cells as Targets  for CTL 
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nlcr-labeled target cells  Passage  Friend LV titer  number 
Degree of lysis (CI50) 
CTL anti-  CTL anti-H-2 b 
HFL/b 
SFFU/ml 
HLF/b (uncloned)  132  20  300:1  1.6:1 
Clone B  55  >5 ×  103  50:1  1.5:1 
Clone B-1  40  4.5 ×  10  a  100:1  1.5:1 
Clone B-2  35  >5 ×  103  15:1  1.0:1 
Clone C  57  4.0 ×  103  40:1  5.0:1 
Clone C-4  40  20  >300:1  5.4: l 
Clone C-10  40  3.0 ×  103  90:1  3.0: I 
Clone C- 11  40  4.0 ×  l0  s  30:1  1.0:1 
Clone C-14  40  3.5 ×  103  50:1  1.4:1 
Clone C-15  40  2.0 X 103  30:1  1.6:1 
Ceils from each clone were labeled with Na2[SlCr]O4 and used as targets to CTL in a 15-h 
cytotoxicity assay. CTL were generated in syngeneic secondary MLTC against uncloned 
HFL/b tumor cells, and in allogeneic secondary MLC against H-2 n alloantigens. 
Friend  LV,  clone  C-4  cells  retained  the  viral  genetic  material  coding  for  the  cell 
surface antigens examined. 
Lysis  of HFL/b  Cloned  Cells  by  CTL.  In  a  further  attempt  to study  the  antigenic 
structure of HFL/b cells, various HFL/b clones were assayed for susceptibility to lysis 
mediated  by syngeneic CTL generated  against  uncloned  HFL/b  cells.  A  long-term 
(15  h)  5XGr-release  cytotoxicity  assay  was  used  to  detect  all  cytolytic  reactions, 
including very weak reactions that would pass undetected  with shorter assays. That 
these cytotoxic lymphocytes were indeed of the T  cell lineage was indicated by their 
high degree of specificity  for Friend  LV-induced  but  not  Gross  LV-induced  tumor 
cells (see below), by their susceptibility to the cytotoxicity of AKR anti-Thy-1.2 serum 
in the presence but  not  the absence of complement,  and by the persistence  of their 
activity after removal of macrophages and other phagocytic cells  (data not shown). 
The  experiment  summarized  in  Table  II indicated  that  cells  actively producing 
infectious Friend LV were more susceptible to lysis induced by HFL/b-specific CTL 
than low-producer cells; in fact, at least  20-fold fewer CTL were required  to destroy 
104 cells from clone B-2 than an equivalent number of cells from clone C-4 (i.e.,  CI50 
values of 15:1  versus  300:1).  However, when the same cells were used as targets  for 
alloimmune CTL specific for H-2 b antigens, no major differences in susceptibility  to 
lysis  could  be  observed  (Table  II),  thus  indicating  that  none  of the  clones  was 
inherently  resistant  to CTL-mediated  lysis.  A  similar  correlation  between  low virus 
production and relative resistance to tumor-specific CTL was detected with a series of 
low-producer and nonproducer clones (Table III), which contrasted with the suscep- 
tibility to lysis exhibited by high-producer clones B-2 and L. 
Specificity  of HFL/b-immune  CTL.  Fig.  5  shows  that  BALB.B  CTL  immune  to 
HFL/b cells and generated in secondary MLTC were specific for H-2 b FMR-positive 
tumor target  cells.  These CTL killed  H-2 b RBL-5 cells  (induced  by Rauscher  LV) 734  CYTOLYTIC  T  LYMPHOCYTES  AND  FRIEND  VIRUS 
TABLE  III 
Correlation between Friend L V Production by Cloned HFL/b Cells and Susceptibility to Lysis by HFL/b- 
specific CTL 
Passage  Friend LV  51Cr-labeled target  Num- 
cells  titer  bet 
Lysis (percent specific 5tCr release)* 
100:1  10:1  l:1  0.1:1 
CI~o 
SFFU/ml 
Clone B-2  61  22 X  10  a  85  64  56  39  0.7:1 
Clone L  105  1 X  10  a  72  47  28  19  14:1 
Clone C-4  66  0  30  17  9  5  >100:1 
Clone HFL/b-3~  2  35  36  11  0  0  >I00:1 
Clone HFL/b-4  2  7  43  17  4  0  >100:1 
Clone HFL/b-5  2  0  37  15  4  4  >100:I 
Clone HFL/b-6  2  0  38  8  0  0  > 100:1 
Clone HBL/b-7  2  0  12  2  0  0  >100:1 
Clone HFL/b-8  2  0  35  13  5  4  >100:1 
Clone HFL/b-9  2  0  38  8  4  0  >100:1 
Clone HFL/b-10  2  25  26  6  0  0  >100:1 
Clone HFL/b- 11  2  0  22  12  0  0  >100:1 
Clone HFL/b- 13  2  19  35  18  3  0  >100:1 
CTL were generated in syngeneic secondary MLTC against uncloned HFL/b tumor cells, and assayed 
for cytotoxicity on 104 51Cr-labeled cloned HFL/b cells in a  15-h assay, 
* Multiple threefold lymphocyte dilutons were used; however, only a selection of lymphocyte:target cell 
ratios is represented, for the sake of brevity. 
:1: Clones HFL/b-3 through HFL/b-13 were derived from uncloned HFL/b cultures at passage No.  165, 
when the latter were producing very low amounts of infectious Friend LV (cf. Fig. 2). 
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Fro.  5.  Specificity of BALB.B CTL generated against uncloned HFL/b cells in secondary MLTC. 
CTL activity was detected in a 6-h cytotoxicity assay using four different 5~Cr-labeled  tumor cell 
lines as targets: 0, RBL-5 (H-2b); II, HFL/b clone B-2 (//-2b); &, LSTRA (H-2d); 1"3, B.GV (H- 
-2b). 
and  HFL/b  clone  B-2  cells  in  a  6-h  cytotoxicity  assay.  Allogeneic  (H-2 d)  FMR- 
positive LSTRA  cells (induced by Moloney  LV) and syngeneic (H-2 b) FMR-negative 
B.GV cells (induced by Gross LV)  were not attacked  by the same CTL. 
Other  experiments  were designed  to study  the finer specificity of HFL/b-immune 
CTL  by cold target competitive inhibition of cytolysis. A  6-h 51Cr-release cytotoxicity FERNANDO  PLATA,  MAUREEN  M.  GOODENOW,  AND  FRANK  LILLY  735 
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Fla.  6.  Competitive  inhibition  of BALB.B  anti-HFL/b  CTL  with  unlabeled  target  cells.  The 
specificity of 12TL-mediated lysis of 5112r-labeled  HFL/b clone B-2 target cells was studied in a 6-hr 
competition assay with  the following unlabeled tumor cells:  HFL/b  clone B-2 cells (O),  HFL/b 
clone 12-4 cells (O), Gross LV-induced B.GV cells (I), and normal BALB.B spleen cells (I-q). Percent 
specific cytotoxicity in the absence of competitor cells was 23%. 
assay was used to detect whatever fine differences in inhibitory capacities might exist 
among  various  tumor  cells.  When  cells  from  Friend  LV-producer clone  B-2  and 
nonproducer clone C-4 were used as cold target cells to compete with ~lCr-labeled 
clone B-2 target cells for lysis mediated by HFL/b-specific CTL, both types of cold 
target  cells  competed equally  well  (Fig.  6).  However, when  syngeneic Gross  LV- 
induced B.GV cells were used as cold competitor cells, 20-fold more B.GV cells than 
clone C-4 or B-2 cells were required to achieve the same degree of inhibition;  this 
difference increased to 40-fold when normal BALB.B spleen cells were used as cold 
competitors. A similar pattern of inhibition was observed when clone C-4 cells were 
used as 5XCr-labeled  targets, instead of cells from clone B-2 (data not shown). These 
results confirmed the indications of fine viral specificity among HFL/b-immune CTL, 
because  Friend  LV-induced  tumor  cells  competed  better  than  Gross  LV-induced 
tumor cells.  It was also apparent  that  cells from nonproducer clone C-4 expressed 
tumor antigens  in  amounts  sufficient to block cytolysis as  efficiently as cells  from 
producer clone B-2. 
Stimulating Capacity of HFL/b Cells in Secondary MLTC.  In another series of experi- 
ments, we considered the ability of x-irradiated HFL/b cells to present tumor antigen 
in secondary MLTC, and thus to induce lymphocyte differentiation and generation 
of HFL/b-specific CTL.  Preliminary  screening experiments  (Table  IV)  indicated 
that,  contrary to expectations, Friend  LV-produeing clones were considerably less 
efficient in inducing CTL generation than nonproducer clones. Thus, at a fixed ratio 
of 10 responding spleen cells to 1 stimulating tumor cell, Friend LV-producer clones 
were  at  least  300  times  less  efficient  in  eliciting  HFL/b-specific CTL  than  low- 
producer uncloned HFL/b cells or clone C-4 cells. 
In view of the contrast between these results and those presented in the previous 
sections, the stimulating capacities of Friend LV-producing clone B-2 and nonpro- 
ducing clone C-4 were studied in greater detail by means of a dose-response titration. 
For  this  purpose,  microcultures  were  established  by  adding  various  numbers  of 
stimulating  tumor cells to 5  ×  106 spleen cells from HFL/b-primed BALB.B mice. 
The number of CTL generated per micro-MLTC was quantitated in a short-term (6 736  CYTOLYTIC  T  LYMPHOCYTES  AND  FRIEND  VIRUS 
TABLE IV 
HFL/b Cells as Stimulators  of CTL Differentiation  in Secondmy ML TC 
Passage  Friend LV titer  Stimulating cells  Number 
CTL generation in second- 
ary MLTC 
Viable 
cells re-  CI~o 
covered 
SFFU/ml  × 10 -6 
HFL/b  132  20  1.9  1:1 
Clone B  55  >5 ×  103  1.5  >300:1 
Clone B-I  40  4.5 ×  10  a  0.7  >300:1 
Clone B-2  35  >5 ×  103  0.8  >300:1 
Clone C  57  4.0 x  10  a  1.5  >300:1 
Clone C-4  40  20  1.5  0.6:1 
Clone C-IO  40  3.0 ×  10  a  1.9  >300:1 
Clone C-ll  40  4.0 ×  10  a  2.0  300:1 
Clone C-14  40  3.5 ×  10  a  1.5  >300:1 
Clone C-15  40  2.0 ×  10  a  1.2  300:1 
MLTC were established by mixing 5 x  106 HFL/b-immune BALB.B spleen cells with 0.5 
×  10  ° x-irradiated (5,000 rad)  stimulating tumor cells in  2 ml  MLTC  medium.  After 
incubation for 7 d, each culture was tested for cytotoxicity on 51Cr-labeled  clone B-2 cells in 
a 15-h assay at various effector:target cell ratios. 
h)  51Cr-release  cytotoxicity  assay,  to  arrive  at  a  minimum  estimate  of  the  CTL 
number.  Results were expressed in terms of LU, as calculated from the dose-response 
cytotoxicity  curves  obtained  for  each  individual  MLTC.  Table  V  summarizes  a 
typical  dose-response  experiment  in  which  it  became  apparent  that  Friend  LV- 
producing cells (i.e., clone B-2 cells) could indeed stimulate CTL generation, but that 
this capacity was  restricted to a  narrow  range,  such  that  highest  CTL  values were 
obtained at a  ratio of 83 responding spleen cells to  1 stimulating tumor cell (i.e., 6  × 
104 tumor cells per culture), and no CTL generation could be detected at ratios of 10: 
1 (i.e., 5  ×  105 tumor cells per culture)  or higher. In contrast, cells producing low to 
undetectable  levels of virus  (i.e.,  uncloned  HFL/b  cells and  clone C-4  cells)  were 
capable of eliciting high  levels of CTL  generation over a  considerably wider range, 
including ratios of 10:1  through 83:1  (i.e., from  5  X  105 to 6  ×  104 stimulating cells 
per culture).  Furthermore, a  mixture of cells obtained by combining clones B-2 and 
C-4  in equal  numbers showed  a  restricted range of stimulating capacity (Table V). 
CTL  generation  could  no  longer be  detected with  5  ×  l0  s  B-2  +  C-4  cells. These 
results thus  indicated that  Friend  LV-producing cells could  indeed stimulate CTL 
generation  in  MLTC,  but  their  stimulating  capacity  was  best  observed  with  low 
numbers of stimulating cells per culture; in fact, they appeared to interfere with CTL 
generation at high doses. 
Other experiments showed that  the inhibition of CTL  generation with  5.0  ×  105 
clone B-2 cells was probably a  result of the production of infectious Friend LV by the 
x-irradiated stimulating cells during the initial phases of lymphocyte culture. Table 
VI  shows  that  fixation  of clone  B-2  cells with  0.15%  glutaraldehyde  (instead  of x- 
irradiation) diminished the inhibitory potential of clone B-2 cells, and relatively high FERNANDO  PLATA,  MAUREEN  M.  GOODENOW,  AND  FRANK  LILLY 
TAnt.E  V 
Dose-Response Studies of CTL Generation in Secondary ML TC 
737 
CTL generation in MLTC (day 7) 
Stimulating cells (5,000  Stimulating cells  Viable  LU/106  LU/cul- 
rad)  per culture  cells re- 
cells  ture  covered 
HFL/b (226)* 
×lO  -6  ×10  -6 
1.00  2.1  0  0 
0.50  1.6  4.0  6.4 
0.17  1.6  6.2  10.0 
0.06  2.1  4.0  8.4 
0.02  2.0  0.5  1.1 
Clone B-2 (114)  1.~  1.2  0  0 
0,50  1.4  0  0 
0.17  1.9  1.2  2.3 
0.06  1.9  4.2  8.0 
0.02  2.1  1.3  2.7 
Clone C-4 (118)  1.00  1.7  0  0 
0.50  2.0  1.7  3.4 
0.17  1.8  6.2  11.2 
0.06  2.0  7. l  14.2 
0.02  1.7  0.4  0.7 
B-2 +  C-4 (1:1  mix)  1.00  1.2  0  0 
0.50  1.8  0  0 
0.17  1.8  8.3  15.0 
0.06  2.1  12.5  26.2 
0.02  1.9  1.2  2.4 
5  X  106 HFL/b-immune BALB.B  spleen cells were  mixed with  variable  numbers of x- 
irradiated  stimulating tumor cells in 2  ml culture medium and incubated  for  7 d.  CTL 
generation was determined by assaying each culture for cytotoxicity with ~Cr-labeled clone 
B-2 target cells at different effector:target cell ratios in a 6-h assay. 
* Passage number is in parentheses. At this stage uncloned HFL/b cells were producing 30 
SFFU/ml, clone C-4 cells were not producing detectable levels of Friend LV, and clone 
B-2 cells were producing 3,500 SFFU/ml. 
numbers of CTL could be generated with 5 ×  105 glutaraldehyde-fixed clone B-2 cells 
(i.e., a ratio of 10 responding spleen cells to 1 stimulating tumor cell), in contrast with 
the  lack of response  observed  at  this  same ratio  with  x-irradiated  clone  B-2  cells. 
Finally, it was also observed that cells from nonproducer clone C-4 did not stimulate 
efficiently in MLTC after glutaraldehyde treatment, 
Table  VII  presents  further  evidence  for  the  inhibition  of CTL  generation  by 
infectious Friend LV in MLTC: addition of 650-26 SFFU  (obtained from a culture 
of clone B-2 cells) inhibited CTL generation in MLTC more than threefold. Addition 
of supernate  from clone  C-4  cells  did  not  inhibit  CTL  generation  in  MLTC  but 
actually seemed to potentiate it. 
Discussion 
The studies described in this report were centered around three aspects of the HFL/ 
b  tumor cell line: First, HFL/b cells were studied as a cell population which actively 738  CYTOLYTIC  T  LYMPHOCYTES  AND FRIEND VIRUS 
TABLE VI 
Comparison of x-irradiated and Glutaraldehyde-fixed HFL/b Cells as Stimulators in ML TC 
CTL generation in MLTC (day 7) 
Stimulat- 
Stimulating  Treatment  ing ceils  Viable 
cells  LU/IO  6  LU/cul-  per culture  cells re-  cells  ture  covered 
Clone B-2  5,000 rad 
×10  -6  ×10  -e 
0.50  1.7  0  0 
0.17  1.6  5.9  9.4 
0.06  2.3  1.7  3.9 
Clone B-2  Glutaraldehyde  0.50  2.9  3.3  9.6 
0.17  3.4  2.2  7.6 
0.~  2.8  1.2  3.3 
Clone C-4  5,000 rad  0.50  1.8  1.4  2.5 
0.17  1.6  9.1  15.0 
0.06  2.0  4.0  8.0 
Clone C-4  Glutaraldehyde  0.50  2.4  0.3  0.7 
0.17  2.6  0.8  2.1 
0.06  2.2  0.6  1.4 
Clone  B-2 cells (passage No.  122) and clone C-4 cells (passage No.  126) were either x- 
irradiated (5,000 rad) or fixed with 0.15% glutaraldehyde,  and added in variable doses to 5 
X 10  n HFL/b-immune BALB.B spleen cells in 2 ml culture medium. After 7 d incubation, 
each culture was assayed for the presence of CTL on 51Cr-labeled clone B-2 cells in 6-h 
cytotoxicity assay at various lymphocyte:target  cell ratios. 
produced  infectious Friend  LV  and  eventually lost  this  capability.  Second,  cloned 
HFL/b  cells were studied as targets for tumor-specific CTL. Third, HFL/b  cells were 
studied as inducers of CTL differentiation in MLTC. 
Arrest of virus production by cell lines previously producing infectious virus had 
been observed, but  little information concerning this phenomenon  was available. A 
fundamental question concerning such an observation is: did each of the cells in the 
population cease virus production  more or less synchronously, or were cells present 
which either never had produced virus or ceased doing so as a  rare event, and these 
nonproducers went on to become the exclusive survivors by virtue of an advantage in 
growth rate? 
Our  studies  of the  arrest  of Friend virus production  by the previously uncloned 
HFL/b  tumor line provide a  first-level answer to this cluestion. Analysis of this line 
indicated that  it contained  both  (a)  cells giving rise to clones that  maintained high 
levels of virus production far beyond the detection of arrest in the parent population 
and (b) cells giving rise to clones that produced very low levels of infectious virus and 
eventually lost all capacity to produce virus (Fig. 2). This finding suggests that, at the 
time  of initial  cloning,  the  population  consisted  of both  high-producer  and  low- 
producer cells, though  the  former constituted  the  vast  majority. Thus  the arrest  of 
virus production  in  this line was probably a  result of a  slight growth  advantage of 
low-producer  cells,  allowing  them  to  overgrow  the  producer  cells;  growth  curve 
analysis,  however,  failed  to  reveal  this  small  difference  (data  not  shown).  These 
observations also suggest that the occurrence of low-producer cells possessing growth FERNANDO  PLATA,  MAUREEN  M.  GOODENOW,  AND FRANK LILLY 
TABLE VII 
Regulation of CTL Generation in ML TC by Tumor Cell Culture Supernates 
739 
CTL generation in MLTC (day 7) 
Supernate added to  Relative 
MLTC*  Viable cells  LU/10  e cells  LU/culture  ratio:~ 
recovered 
× I0 -6 
MEM  1.7  8.5  14.4  1.00 
B-2 (1/1)  1.8  1.7  3.1  0.22 
B-2 (1/5)  2.0  2.8  5.6  0.39 
B-2 (1/25)  1.8  2.5  4.4  0.31 
B-2 (1/125)  1.7  7.0  11.9  0.83 
C-4 (1/1)  1.5  25.0  37.5  2.60 
C-4 (1/5)  2.0  12.5  25.0  1.74 
C-4 (1/25)  2.0  9.3  18.6  1.29 
C-4 (1/125)  1.4  7.7  11.1  0.77 
MLTC were established with 5 ×  106 HFL/b-immune BALB.B spleen cells, 0.2 ×  106 x- 
irradiated (5,000 rad) clone C-4 cells, and 0.5 ml cell-free culture supernate. The vol was 
adjusted to 2.0 ml with MLTC medium,  and the cultures were incubated for 7 d. CTL 
activity was detected  by assaying each culture on 51Cr-labeled clone B-2 cells at various 
lymphocyte:target cell ratios in a 6-h cytotoxicity assay. 
*  Cell-free culture supernates were prepared from 24-h cultures of 5 ×  106 clone B-2 or clone 
C-4 cells, as described in Materials and Methods. Each supernate  assayed in MLTC was 
also titrated in vivo for SFFV activity; clone B-2 supernate contained  1,100 SFFU/ml, and 
clone C-4 supernate was negative. 
Calculated as the quotient  of each experimental  value (in LU/culture) divided by 14.4 
LU/culture. 
advantage was a  rare event among HFL/b  cells. Superinfection of nonproducer cells 
by virus from producer cells would not be expected to occur, however, because low- 
producer and nonproducer clones were strongly viral glycoprotein gp69/71-positive 
(Table I), so that their virus receptor molecules would be blocked (21). 
Arrest of virus  production  by  HFL/b  cells presumably  represented  a  change  of 
phenotype rather than of genotype. Consequently, nonproducer cells must retain the 
SFFV and FMuLV  genomes. In fact, certain viral antigens continued to be expressed 
by  nonproducer  cells,  and  reactivation  of virus expression  has  been  achieved  by 
treatment  with  iododeoxyuridine  (10).  In  this  context,  Berkower  et  al.  (22)  have 
reported  that  producer  B-2  and  nonproducer  C-4  clones  showed  differences  in 
cytoplasmic viral RNA  expression, and  that  arrest  of virus production  appeared to 
reflect deficient FMuLV  transcription. 
Serological tests  for  cell surface  expression  of various  viral  and  H-2  antigens  in 
individual HFL/b  clones failed to  reveal any major differences between  high-  and 
low-producer clones. Both types of clones expressed high levels of viral glycoprotein 
gp69/71  at the cell surface, but low to undetectable levels of viral structural proteins 
p30 and p 12. Consequently, the relatively high concentrations of p30 and p 12 proteins 
previously detected in soluble extracts of producer HFL/b  cells (10)  were probably 
present in the form of cytoplasmic constitutents. 
Our  studies  with  HFL/b-specific  CTL  indicated  that  high-  and  low-producer 
HFL/b  clones expressed at least one major antigenic determinant in common, which 
could  be  recognized by  HFL/b-specific CTL.  Two  candidates  for  this  antigen  are 740  CYTOLYTIC T  LYMPHOCYTES AND FRIEND VIRUS 
viral envelope glycoprotein gp69/71 and c~llular FMR antigen, both governed by the 
helper FMuLV genome. Enjuanes et al.  (23)  have recently demonstrated that  cell- 
surface viral glycoprotein gp69/71  antigen was a  major determinant recognized by 
murine leukemia virus-specific CTL in another syngeneic tumor system. Viral struc- 
tural gag proteins p30 and p 12, on the other hand, appeared to be of minor importance 
for CTL recognition of target tumor cells in our HFL/b system, because all clones, 
regardless of virus-producer status,  expressed low to undetectable amounts of these 
antigens. 
It is probable that  tumor-immune CTL comprise various independent subsets of 
cytotoxic cells that recognize antigenic determinants of different specificities particular 
to the tumor in question. GiUis et al. (4) have recently shown that a subpopulation of 
CTL directed to a SFFV-specific antigen can be obtained in a syngeneic tumor system 
involving immunity to Friend erythroleukemia cells. Another aspect of SFFV-specific 
antigens has been described by Risser (24) with serological studies that indicated that 
SFFV-specific antigens are similar to tissue-specific differentiation antigens. The latter 
appear to be expressed selectively in a subpopulation of hemopoietic cells in strains of 
mice carrying the Fv-2  s allele. HFL/b-immune CTL probably include cytotoxic cells 
specific for antigens determined by both the helper FMuLV and the SFFV genomes. 
It was unexpected that virus-producer HFL/b cells were markedly more sensitive 
to lysis by syngeneic CTL than were nonproducer cells.  Because both types of cells 
were comparably susceptible to anti-H-2 b CTL, no clone was inherently resistant to 
CTL-mediated  lysis.  Although  studies  of Meruelo  (25)  suggested  that  increased 
expression of H-2 antigens might result in increased susceptibility to syngeneic tumor- 
immune CTL, we detected no difference between high and low producer clones with 
respect to H-2.2 antigen expression. Finally, cold target cell competition assays showed 
that both high producer and nonproducer HFL/b cells expressed tumor antigen(s) in 
amounts  sufficient  to  compete  comparably  for  CTL-mediated  lysis.  Thus,  the 
heightened expression of target antigens in high-producer HFL/b cells did not render 
them better competitor cells. The identity of these target antigens remains to be better 
defined. Our  results suggest  that  they are not  all  identical  to  the  FMR  and  viral 
glycoprotein  gp69/71  antigens  detected  serologically,  because  our  producer  and 
nonproducer clones expressed roughly equivalent amounts of the latter. The use of 
monoclonal antibodies might help define the relevant target antigens in the future. 
Having  established  that  active  Friend  LV  production  by  clone  HFL/b  cells 
correlated with a high susceptibility to attack by HFL/b-immune CTL, we proceeded 
to  investigate  the  ability  of the  same  HFL/b  clones  to  induce  the  generation  of 
HFL/b-specific CTL in secondary MLTC. Our results indicated that  low-producer 
clones were capable of stimulating CTL differentiation over a  relatively wide range 
of responding spleen cell-to-stimulating tumor cell ratios. High-producer clones were 
also efficient stimulators of CTL differentiation when added in small numbers to the 
lymphocyte cultures; however, the same cells inhibited CTL differentiation at higher 
doses.  Further experiments revealed that  this  inhibitory capacity of high producer 
cells required metabolically active stimulating  cells, and  that  it could be partially 
reproduced with nonproducer cells by adding 50 or more SFFU of Friend LV to the 
lymphocyte cultures. This circumstantial evidence suggested that in spite of x-irradia- 
tion, high producer cells continued to produce virus for a  period of time in MLTC, 
and that the virus released interfered with CTL differentiation in vitro. An analogous FERNANDO PLATA, MAUREEN M.  GOODENOW, AND FRANK LILLY  741 
pattern  of interference  by  Friend  LV  on  the  differentiation  of immunoglobulin- 
producing B cells in vitro was observed by Kamo et al. (26), who found evidence for 
the  active  inhibition  of specific  immunoglobulin  production  by  free  Friend  LV 
secreted in the lymphocyte cultures by infected spleen cells. 
The totality of these experiments thus indicates that Friend LV-induced tumor cells 
can vary radically in  their ability to produce virus, that  those  tumor cells actively 
producing large amounts of virus are the most susceptible to attack by tumor-specific 
CTL,  and  that  active  Friend  LV  production  can  inhibit  CTL  differentiation  in 
MLTC. In general, these facts imply that LV-induced tumors can affect the immune 
response directed  against  them by modulating  their capacity to produce infectious 
LV and, concomitantly, modulating their antigenic identity. 
Summary 
The HFL/b tumor cell line, induced by Friend erythroleukemia virus in BALB.B 
mice, was used to study the relation between virus production or nonproduction and 
the  antigens  recognized  by  Friend  virus-specific  cytolytic  T  lymphocytes  (CTL). 
Analysis  of clones  and  subclones  of these  tumor  cells  revealed  a  high  degree  of 
heterogeneity  with  respect  to  the  production  and  release  into  culture  fluids  of 
infectious Friend virus in vitro, ranging from high levels to low or undetectable levels 
of virus production. 
Although  no  major  differences  could  be  detected  among  the  antibody-defined 
serotypes of the various clones, the susceptibility of cells of individual HFL/b clones 
to attack by Friend virus-specific CTL varied widely, and those clones which produced 
large amounts of infectious virus provided the most sensitive target cells. It was also 
apparent that production of infectious Friend virus was inhibitory to CTL generation 
in syngeneic mixed leukocyte-tumor cell cultures.  Friend erythroleukemia virus-pro- 
ducing  cells  thus  appeared  to  interact  in  a  complex  manner  with  the  host  CTL 
response by modulating their production of infectious Friend virus. 
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